Our management team combines all the staff and R&D managers established under "Ram Group Open Innovation Labs" since 2010. Our managers are all acclaimed innovators and industry veterans in Atomic Engineering of Functional 2-Dimensional Materials, Nano-Fabrication, Nano-circuitry and profound Bio-Engineering, Software and ICT (Information and Communication Technology) expertise, combined with over 40 years in Bio-Chemistry functionalization and surface modification of nano-sensors, making our Management Team uniquely qualified to manage our global R&D and Innovation teams, as well as being uniquely equipped to interface with the global Med-Tech/Bio-Tech industries.

We have some of the leading scientific minds who are at the forefront of sensor and transducer development and fabrication, each operating at the Company’s services development facilities in Israel, Germany and Singapore. Each and every one of our global R&D groups are managed by our team leaders who make up our highly specialized and elite group of innovators and trailblazers for the research, development and commercialization of our various leading-edge sensing technologies.

Our advisory board brings together key experts in a variety of fields from around the world with a wealth of experience garnered over decades of industry and academic leadership and involvement. Ram Group’s advisory board is comprised of key innovators and trailblazers dealing with the building blocks of next-generation sensor and transducer principles. With over 450 worldwide publications between them, featured in many of the world’s leading scientific and medical journals, the Company’s advisory board is led by the brilliant minds at the forefront of healthcare policy, digital-healthcare, physics, engineering and chemistry.

In 2015, Ayal Ram founded Ram Group, who himself suffered from non-Hodgkin’s lymphoma cancer which nearly ended his life prematurely. Realizing that his disease and 80% of today’s chronic diseases from which millions of patients around the world suffer are preventable and unnecessary. Mr. Ram personally experiencing the limitations of current health technologies understood the great and unmet need that existed within the global healthcare community for new innovative technologies capable of detecting similar types of chronic diseases early on.

It was this need for life-saving innovation which fueled Mr. Ram’s mission and calling to create Ram Group, and bringing together an international team of the world’s leading scientist and engineers, from which multiple revolutionary and breakthrough diagnostic platforms were developed and are now able to avert millions of premature deaths and help promote a better quality of life for millions more.

We have grown from a small innovation lab into cutting-edge organization focused on the realization of disruptive next-generation sensor technology solutions with development facilities in Singapore, Israel, Germany and an international team of business executives to promote and market our technologies in the global marketplace.

Our mission is to introduce market disruptive devices which support entire sensing and monitoring ecosystems (e.g., medical, health, Industrial, oil & gas, petrochemical and fin-tech biometrics) through a single device interface that can seamlessly integrate into connected (internet-of-things) products capable of performing the full range of diagnostics and wearable health tools, screening for population health management and remote monitoring by doctors. Provide turn-key solutions for process analytics for industrial monitoring of oil & gas, petrochemical production, non-destructive testing and structure-material health industrial monitoring applications.

Ram Group bases its entire Corporate Structure and Corporate Values on "Category Leadership." Our values of responsibility, creativity, teamwork, and excellence based on our personal identification with the unmet needs of our global communities, who are in desperate need for practical solutions to the many critical issues facing humanity today. We carry with us the deep understanding that "He who has health, has hope. And he who has hope, has everything." 

We believe the battle over universal healthcare isn’t about charity, but about Value-Based-Care and Category Leadership. We take pride in all our accomplishments so far. But ultimately we have only one definition of success: Innovative solutions that produce tangible improvements in people’s lives. Our disruptive innovation solutions are born out of the values that we hold each of our Corporate Executives and Partners to.

To learn more about our Corporate Values, Click Here.

Today’s global health and equality needs are constantly rising; we believe it is our responsibility to create life changing technological solutions that will have life-defining benefits to all individuals at all levels of socioeconomic status. Our commitment to value-base-care is paramount to every one of our product development processes.

From inception, we have invested in high-risk, high-reward research targets; an approach that in 6 short years has transformed the broader approach in the chronic disease management field, population health management, and industrial automation and testing. As a Company we only focus on technologies which are currently believed to be beyond today’s scientific development capabilities, and out of reach to today’s scientific community, only through our obsession with the impossible are we fulfilling our responsibility of creating a global difference for our next generation.

We see the greatest hurdle to widespread access to medical diagnostics is its dependency on complex machines that are very expensive and require dedicated facilities with highly trained technical staff. Global diagnostics industry’s greatest scientific challenge, is to create a disposable, handheld, and universal diagnostics platform, capable of using reagents of any type, in a rapid quantitative multi-analyse testing platform which seamlessly connects to mHealth applications and other wireless infrastructure. To overcome this seemingly insurmountable hurdle our nano-technology development team has been developing the world’s first universal diagnostic platform. As of March, 2016 our elite team of scientists and engineers from around the world have developed the world’s first, universal biomarker handheld diagnostic platform. Our new revolutionary technology platform features the use of disposable single-step cartridges, label-free measurement of up to 64 tests simultaneously (next ver. over 1000), transmits results directly to any smartphone or device via Bluetooth and supports nearly every type of reagent, providing results within minutes and is able to use whole blood directly from a patients finger. Our detection sensitivity in comparison to the existing systems used at modern laboratories is up to a million times more sensitive, detecting concentration as low as femto-mol (10-15)!

Our diagnostic platform eliminates the need for expensive facilities and complex laboratory procedures by offering the same diagnostic capabilities in a handheld, portable device using disposable all-in-one label-free diagnostic sensors and delivering the entire hospital laboratory’s capability in the palm of your hand and results within minutes.

The first of its kind in the world. We have developed a wearable sensor technology which is able to provide the full spectrum of total body monitoring capable of real-time monitoring of major organs in the human body. Through the introduction of our innovative and one-of-a-kind technology both users are now able to monitor quickly and non-invasively all of their heart, lungs and intestine functions and dynamics, enabling for the first time a handheld mobile platform for chronic disease monitoring and comprehensive health & fitness monitoring. Additionally, our non-invasive sensing platform provides early acute event warning (e.g. heart attack, stroke, atrial fibrillation, asthma attack and other life threatening conditions), and nutrition monitoring and management of an individual through direct monitoring of the individual’s gastrointestinal, all through a single-point and completely non-invasive integrated PCB chip for use in smartphones and other smart-wearable devices.

Have you ever stop to think how silly and also how dangerous it is to live our lives with absolutely no monitoring of our body's medical status? Millions and millions of diagnostic procedures are performed every year for the detection and management of chronic disease, what if you could make them painless, non-invasive and available anytime/anywhere and take most of the risk out of the procedures. With that in mind we developed the world’s first completely non-invasive professional screening and diagnostic tool. The realization of the innovative tool represents a major breakthrough in the global fight against chronic disease. Using our tool medical professionals are able to place the tool on a few key spots on the body and the patient’s comprehensive results are immediately provided to the physician without any additional infrastructure of equipment. In comparison it would take multiple tests and many different diagnostic systems to offer the same testing which would also take a couple days and multiple visits to the doctor.

Today's global community is becoming more health conscious than ever before. Health & fitness tracking and activity wearables are becoming more and more common place. Our revolutionary wearable technology will introduce the next generation and evolution in health, wellness and fitness monitoring devices, going beyond activity, heart rate and body temperature.

Our technology introduces capability of tracking of the individual's internal functions and vital signs, breathing, energy excursion, blood flow, energy use and full body monitoring all in a single wearable device which can be placed on any single-point on the body providing users with real tracking and monitoring of their full health profile for complete peace of mind.

Diabetes monitoring is not a new topic and is a well-defined market with mature products and methodologies. Our new generation of sensors will redefine the patient-device and the patient-doctor experience completely. Introducing a completely new type technology sensing platform diabetics will be able to perform glucose testing without the need for a finger prick and completely non-invasively, and will be empowered to perform regular HbA1c testing minimal-invasively at the doctor’s office during routine checkups as often as every 2 – 3 weeks, compared to existing systems which can only be performed every 4 months.

Clinical hematology is an intensive, exciting, rewarding and demanding specialty. It includes the study of aetiology, diagnosis, treatment, prognosis, and prevention of blood diseases that affect the production of blood and its components. These include white blood cells, red blood cells, hemoglobin and platelets. It is characterized by a holistic approach to clinical care and encompasses both clinical and laboratory practice. Laboratories and physicians will use our handheld mobile analyzers to provide clinical interpretation of clinical data of blood and bone marrow specimens. We believe that using our knowledge and experience we can help hematology practitioners – both with respect to their clinical capabilities and by making their lives just that little easier with the next generation of mobile analyzers. We know that by introducing the capability to perform a full blood count on a patient in the doctor’s office using the patient’s blood sample from their finger (much like a glucose test is performed), without having to send out a sample to centralized labs will completely revolutionize the way today’s medical professionals evaluate therapy options and handle the diagnosis of their patients during their patient consults at their office or in remote regions of the world. With the final objective of benefiting the health of their patients. 

Using our next-generation opto-electronic sensor technology we are able to identify specific markers within patients for the individual tailoring of treatment all at the doctor’s office without the need for advanced laboratories and equipment. Our new generation of sensors enable physicians to examine and evaluate on an individual basis the efficacy of specific treatments to patients by testing treatments on patient samples before treatment is ever started.

According to the latest WHO estimates, released in September 2015, there were 214 million cases of malaria in 2015 and 438,000 deaths. One of the greatest challenges to this epidemic is the ability to diagnose the disease in regions such as Sub-Saharan Africa and South Asia where access to clinical facilities are limited if even existent. Rapid diagnostic kits are available on the market but limited to Yes/No results, easily affected by temperature and are too costly for NGOs. Ram Group is the first company in the world to introduce a completely non-invasive diagnostic device which can test for the disease through skin contact and provide extensive information on the patient and disease status, with the ratio of disease cells versus healthy red cells.

Our goal is not to be a competitor in an already-existing market space, but to define new spaces or lead and grow existing ones. Our purpose is to identify unmet needs and new market opportunities of tomorrow, and then define and realize new innovative solutions through our in-house research and development facilities and innovation teams.

Because basic research focuses on isolated functions and not application-oriented solutions, we approach innovation through applied research and development for each of our targeted applications to provide us with the data to verify and quantify the value proposition of each technology solution we develop.

Design and prototyping encompasses the entire process of maturing a new technology from individual components to a complete integrated device solution in which we integrate multiple technologies to realize new products never before seen. From structural elements and nano-fabrication to aesthetic appeal, every aspect focuses on developing a personalized and reliable platform.

With the knowledge that the intrinsic value of a company is based on its patent portfolio, Ram Group has its own in-house intellectual patent division with a variety of patent attorneys, we focus on enhancing IP value through aggressive protection strategies and the translation of each patent into global patent strategies that enable us to better commercialize and protect our products.

We leverage our experience, our CRO's regional expertise, and unparalleled data analytics to plan and execute more efficient trials from first-in-human to post marketing studies.

We know that a hands-on approach to establishing manufacturing processes is the only way to guarantee high quality results and the future capability to mass produce products. Our in-house fabrication facilities can complete everything from clean room micro and nano-fabrication, electronics layout design, PCB assembly and molding parts, final assembly and product design. All of our processes employ methods used by mass production foundries and high-volume assembly plants so that we can quickly market our products to the global marketplace.

We focus on launching special purpose companies or developing licensing strategies structured specifically for each product and technology we introduce into the market place. We recognize that even the most life-changing innovations do not produce impact without a defined, pro-active strategy for market penetration and we are dedicated to completing the most effective monetization event for each product and technology we create.

Our diverse team of scientist and innovators are continually chasing the impossible. As a team we identify within our portfolio of technology developments the most innovative and disruptive technologies which have the potential to change industry realities, then mature those technologies from conceptualization to actualization through commercialization, and offer a variety of monetization strategies.

We have over many years developed a unique and well-structured, detailed plan which defines our technology and products' life-cycle from the moment of innovation to the formation of a special purpose company, formed specifically to monetize the innovation through market entry.

We know that by identifying people's currently unmet needs and developing life-defining products, we will help create the markets of tomorrow. Touching people's lives through technology does more than just make a difference. It determines and defines the markets of the future and thus the revenue flow of the future.

You have the opportunity to help us shape the future of tomorrow.

We know that by identifying people's currently unmet needs and developing life-defining products, we will help create the markets of tomorrow. Touching people's lives through technology does more than just make a difference. It determines and defines the markets of the future and thus the revenue flow of the future.

You have the opportunity to help us shape the future of tomorrow.

We know that by identifying people's currently unmet needs and developing life-defining products, we will help create the markets of tomorrow. Touching people's lives through technology does more than just make a difference. It determines and defines the markets of the future and thus the revenue flow of the future.

You have the opportunity to help us shape the future of tomorrow.